Turnacum SRL
The score of Turnacum shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +121 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Turnacum's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Jun 2026
- Year ended 31 Dec 2024filed on 05 Jun 2025
- Year ended 31 Dec 2023filed on 21 Jun 2024
- Year ended 31 Dec 2022filed on 07 Aug 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Turnacum's financial analysis
- Solvency21.3%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Turnacum
Turnacum's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0886.453.801
- VAT number
- BE0886453801
- Peppol
- Registered · 0208:0886453801 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Dec 2006
- Registered office
- 7500 Tournai
- Latest accounts
- 2025 · filed on 11 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Turnacum (SRL) has been based in Tournai since 2006, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 14,309 € and equity of 5,489 €; its revenue is not published. Its solvency stands at 21.3%, below the median of its sector (43.9%).
Companies similar to Turnacum
Companies in the same business, of comparable size and area, outside its group.
- Zyntra Advisory Research and experimental development on natural sciences and engineering Etterbeek · balance sheet 22,045 €
- Mandible Guide Research and experimental development on natural sciences and engineering Woluwe-Saint-Pierre · balance sheet 64,270 €
- Taikun Pharmaceutical Technology Manufacture of basic pharmaceutical products Ghent · balance sheet 275,396 €
- Apcor R&M Manufacture of basic pharmaceutical products Ghent · balance sheet 5,677 €
- Mythralica Manufacture of pharmaceutical preparations Etterbeek · balance sheet 135,553 €
- Formac Pharmaceuticals Research and experimental development on natural sciences and engineering Leuven · balance sheet 2,112 €
- Flindr Labs Manufacture of pharmaceutical preparations Ghent · balance sheet 262,929 €
- LabOmics Research and experimental development on social sciences and humanities Jette · balance sheet 215,617 €
Frequently asked questions about Turnacum
What is the revenue of Turnacum?
Turnacum files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Turnacum?
In Belgium, the VAT number is the company number prefixed with BE: BE0886453801 for Turnacum, if the company is VAT-registered. Its company number (CBE) is 0886.453.801.
Where is the registered office of Turnacum?
According to the CBE register, the registered office of Turnacum is in 7500 Tournai.
What is the equity of Turnacum?
At the close of the 2025 financial year, the equity of Turnacum amounts to 5,489 €, a solvency of 21.3% of total assets.
Who manages Turnacum?
The register lists 2 active mandates at Turnacum. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Turnacum
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →